EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Research progress on the application of RPA-CRISPR/Cas12a in the rapid visual detection of pathogenic microorganisms

Tuo Ji, Xin Fang, Yuzhi Gao, Kun Yu, Xuzhu Gao

Frontiers in Cellular and Infection Microbiology · 30.07.2025 · 15

DOI: 10.3389/fcimb.2025.1640938 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 30.07.2025. Verfasst von Tuo Ji und 4 weiteren Autor:innen. Beteiligte Einrichtung: Lianyungang Clinical College, Bengbu Medical University and The Second People's Hospital of Lianyungang, Lianyungang, China. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Nucleic Acid Amplification Techniques, Molecular Diagnostic Techniques, Recombinases. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In an increasingly complex global public health landscape, the continuous emergence of novel pathogens and the growing problem of antibiotic resistance highlight the urgent need for rapid, efficient, and precise detection technologies for pathogenic microorganisms. The innovative combination of Recombinase Polymerase Amplification (RPA) and CRISPR/Cas12a enables the rapid amplification of target gene fragments under isothermal conditions and the precise recognition and cleavage of specific nucleic acid sequences. The integration of RPA and CRISPR/Cas12a significantly enhances the sensitivity and accuracy of detection simplifies operational procedures, and reduces the dependence on specialized equipment for testing personnel. This combination demonstrates great potential for application in clinical diagnostics and point-of-care testing. This article provides a detailed overview of the principles of RPA-CRISPR/Cas12a and its latest research progress in the field of pathogen detection, aiming to promote the widespread application of RPA-CRISPR/Cas12a technology in clinical medicine and public health and to offer theoretical support for its further optimization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsNucleic Acid Amplification TechniquesMolecular Diagnostic TechniquesRecombinasesBacteriaHumansPoint-of-Care TestingSensitivity and SpecificityPoint-of-Care SystemsBacterial ProteinsEndodeoxyribonucleasesCRISPR-Associated Proteins

Stichwörter der Autor:innen

CRISPR/Cas12aRPApathogenic microorganismspoint-of-care testingvisualization

Substanzen

RecombinasesCas12a proteinBacterial ProteinsEndodeoxyribonucleasesCRISPR-Associated Proteins

Autor:innen und Institutionen

  • Lianyungang Clinical College, Bengbu Medical University and The Second People's Hospital of Lianyungang, Lianyungang, China.
  • Lianyungang Clinical College, Xuzhou Medical University and The Second People's Hospital of Lianyungang, Lianyungang, China.
  • Department of Central Laboratory, The Second People's Hospital of Lianyungang City (Cancer Hospital of Lianyungang), Lianyungang, China.
  • Medical College, Yangzhou University, Yangzhou, China.

Zitieren

APA

Ji, T., Fang, X., Gao, Y., Yu, K., & Gao, X. (2025). Research progress on the application of RPA-CRISPR/Cas12a in the rapid visual detection of pathogenic microorganisms. Frontiers in Cellular and Infection Microbiology, 15. https://doi.org/10.3389/fcimb.2025.1640938

Vancouver

Ji T, Fang X, Gao Y, Yu K, Gao X. Research progress on the application of RPA-CRISPR/Cas12a in the rapid visual detection of pathogenic microorganisms. Frontiers in Cellular and Infection Microbiology. 2025;15. doi:10.3389/fcimb.2025.1640938

BibTeX
@article{Ji2025,
  author = {Ji, Tuo and Fang, Xin and Gao, Yuzhi and Yu, Kun and Gao, Xuzhu},
  title = {Research progress on the application of RPA-CRISPR/Cas12a in the rapid visual detection of pathogenic microorganisms},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2025},
  volume = {15},
  doi = {10.3389/fcimb.2025.1640938}
}
Kostenlos starten →